Page last updated: 2024-08-17

uridine monophosphate and rg 7128

uridine monophosphate has been researched along with rg 7128 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawitz, EJ; Membreno, FE1
Pockros, PJ1
Bukh, J; Gottwein, JM; Jensen, SB; Li, YP; Pedersen, J; Ramirez, S1
Baronas, V; Haines, K; Klumpp, K; Le Pogam, S; Li, L; Nájera, I; Piso, K; So, SS; Tong, X; Yan, JM1

Reviews

2 review(s) available for uridine monophosphate and rg 7128

ArticleYear
The HCV NS5B nucleoside and non-nucleoside inhibitors.
    Clinics in liver disease, 2011, Volume: 15, Issue:3

    Topics: Antiviral Agents; Clinical Trials as Topic; Deoxycytidine; Guanosine Monophosphate; Hepatitis C; Humans; Sofosbuvir; Uridine Monophosphate; Viral Nonstructural Proteins

2011
Nucleoside/nucleotide analogue polymerase inhibitors in development.
    Clinics in liver disease, 2013, Volume: 17, Issue:1

    Topics: Cytidine; Deoxycytidine; Drugs, Investigational; Enzyme Inhibitors; Hepacivirus; Hepatitis C; Humans; Protein Conformation; RNA-Dependent RNA Polymerase; Sofosbuvir; Uridine Monophosphate; Viral Nonstructural Proteins

2013

Trials

1 trial(s) available for uridine monophosphate and rg 7128

ArticleYear
In vivo emergence of a novel mutant L159F/L320F in the NS5B polymerase confers low-level resistance to the HCV polymerase inhibitors mericitabine and sofosbuvir.
    The Journal of infectious diseases, 2014, Mar-01, Volume: 209, Issue:5

    Topics: Antiviral Agents; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Mutation; Polyethylene Glycols; Recombinant Proteins; Replicon; Ribavirin; RNA, Viral; Sofosbuvir; Uridine Monophosphate; Viral Nonstructural Proteins

2014

Other Studies

1 other study(ies) available for uridine monophosphate and rg 7128

ArticleYear
Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:2

    Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cells, Cultured; Chimera; Deoxycytidine; Genotype; Hepacivirus; Humans; Lead; Liver Neoplasms; Mutation; Peptide Hydrolases; Sofosbuvir; Transfection; Uridine Monophosphate; Viral Nonstructural Proteins

2014